SENSEX    71988.77       -500.22    |    NIFTY    21861.95       -133.90 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Infosys, Wipro, Cipla in focus
13-Oct-20   08:30 Hrs IST

Infosys announced that it has completed the acquisition of Kaleidoscope Innovation, a full-spectrum product design, development and insights firm innovating across medical, consumer and industrial markets, bolstering capabilities in the design of smart products.

Among key result, Wipro will declare its July - September quarterly result today, 13 October 2020.

Cipla said that its step-down associate company in USA, Avenue Therapeutics Inc. (Avenue), a company focused on the development of intravenous (IV) tramadol for the U.S. market, announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the company's New Drug Application (NDA) for IV tramadol.

Godrej Properties announced that it has entered into an outright transaction to purchase a well located land parcel in Sarjapur, Bangalore.

Aster DM Healthcare through its subsidiary, Dr. Moopen's Healthcare Management Services LLC, has acquired 3% stake in Sanad Al-Rahmah Medical Care Company. Pursuant to the aforementioned acquisition the shareholding of the company has increased from 97% to 100%.

Lakshmi Vilas Bank said that a meeting of the board will be held on 15 October 2020 to consider and approve, the issue of securities of the bank to existing shareholders of the bank on a rights basis.

Rane Brake Lining said the company's board of directors will consider a proposal for buyback of equity shares on October 15.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 89.02 1.06
United Kingdom (GBP) 1.17 1.00 104.11 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.80 83.63 1.00
Market News << ALL News
  19-Apr-2024, (08:22 )  SJVN arm incorporate..
  18-Apr-2024, (05:49 )  Infosys Q4 PAT climb..
  18-Apr-2024, (05:25 )  Bajaj Auto Q4 PAT cl..
  18-Apr-2024, (03:39 )  HDFC Life gains afte..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)